Related Experiment Videos
Atherosclerosis in transplant heart
The Journal of the Association of Physicians of India
|February 1, 1996
Summary
Heart transplant atherosclerosis is a rapidly progressive condition that causes rejection and is often asymptomatic. Early diagnosis via intravascular ultrasound and angiography is crucial, with diet and diltiazem showing promise for prevention.
Area of Science:
- Cardiology
- Transplant Medicine
- Vascular Biology
Background:
- Graft atherosclerosis in heart transplants is a significant clinical challenge.
- It is characterized by rapid progression and often remains asymptomatic due to cardiac denervation.
- It is a leading cause of late transplant rejection, occurring typically after one year.
Purpose of the Study:
- To describe the unique characteristics of graft atherosclerosis compared to conventional atherosclerosis.
- To highlight diagnostic methods for early detection of graft atherosclerosis.
- To evaluate treatment and prevention strategies for heart transplant graft atherosclerosis.
Main Methods:
- Review of histopathological differences between graft and conventional atherosclerosis.
- Utilization of intravascular ultrasound and serial coronary angiography for diagnosis.
- Assessment of outcomes with dietary modifications and pharmacological interventions.
Main Results:
- Graft atherosclerosis differs histopathologically from conventional atherosclerosis.
- Intravascular ultrasound and coronary angiography enable early diagnosis.
- Dietary management of triglycerides and prophylactic diltiazem show positive outcomes.
- Surgical interventions like angioplasty and bypass graft surgery offer limited benefit.
Conclusions:
- Graft atherosclerosis is a distinct entity in heart transplant recipients, leading to rejection.
- Early diagnosis is achievable with advanced imaging techniques.
- Preventive strategies focusing on lifestyle and specific medications are effective, while retransplantation may be necessary for some patients.